Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
September 15 2021 - 1:11PM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that members of the senior management team will
present at the following upcoming virtual investor conferences:
- Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Monday, September 20, 2021 at 2:55 pm ET. (access here)
- Cantor Global Healthcare Conference on September 30, 2021 at
12:40 pm ET. (access here)
In order to participate in the audio webcasts, interested
parties can also register and access presentations under
"News/Events” through the “Investors” section of the Aurinia
corporate website at www.auriniapharma.com. A replay of the
webcasts will be available on Aurinia’s website.
ABOUT AURINIA
Aurinia is a fully integrated biopharmaceutical company focused
on delivering therapies to treat targeted patient populations that
are impacted by serious diseases with a high unmet medical need.
The Company recently introduced the first FDA-approved oral therapy
indicated for the treatment of adult patients with active lupus
nephritis (LN). Aurinia’s head office is in Victoria, British
Columbia; its U.S. commercial hub is in Rockville, Maryland; and
the Company focuses development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210915005149/en/
Investor and Corporate Contact: Dana Lynch, Corporate
Communications & IR dlynch@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2024 to May 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From May 2023 to May 2024